debt instruments or recognising the gains and losses on them on different bases; or a group of debt instruments or financial assets and debt instruments is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the entity’s key management personnel (as defined in Section 33 Related Party Disclosures, paragraph 33.6), for example members of the entity’s board of directors and its chief executive officer. Commitments to receive a loan and to make a loan to another entity that meet the conditions in paragraph 11.8(c) shall be measured at cost (which sometimes is nil) less impairment. Investments in non-derivative financial instruments that are equity of the issuer shall be measured as follows (Section 2A provides guidance on determining fair value): For investments in another group entity that are within the scope of this section, the following accounting policy choice shall apply to all investments in a single class, either: at cost less impairment; at fair value with changes in fair value recognised in other comprehensive income (or profit or loss) in accordance with paragraphs 17.15E and 17.15F; or at fair value with changes in fair value recognised in profit or loss. For all other investments: if the instruments are publicly traded or their fair value can otherwise be measured reliably (see paragraph 2A.19), the investment shall be measured at fair value with changes in fair value recognised in profit or loss; and all other such investments shall be measured at cost less impairment. Impairment or uncollectability must be assessed for financial assets in (a), (c), (d)(i) and (d)(v) above. Paragraphs 11.21 to 11.26 provide guidance. A Dividend income from investments in non-derivative financial instruments that are equity 
